Company Filing History:
Years Active: 2016-2018
Title: Barbel Rotthauser: Innovator in Diabetes Treatment
Introduction
Barbel Rotthauser is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of diabetes treatment through her innovative research and development of pharmaceutical solutions. With a focus on combining insulin with GLP-1 receptor agonists, her work aims to improve the management of diabetes for patients worldwide.
Latest Patents
Barbel Rotthauser holds 2 patents related to her groundbreaking work. Her latest patents include:
1. **Combination of an insulin and a GLP-1 agonist** - This invention relates to a drug comprising at least one insulin and at least one GLP-1 receptor agonist.
2. **Combination of an insulin and a GLP-1-agonist** - Similar to her first patent, this invention also focuses on a drug that includes at least one insulin and at least one GLP-1 receptor agonist.
Career Highlights
Barbel Rotthauser is currently employed at Sanofi-Aventis Deutschland GmbH, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, particularly in diabetes care. Her innovative approach has positioned her as a key player in the industry.
Collaborations
Barbel collaborates with various professionals in her field, including her coworker Ulrich Werner. Together, they work on advancing diabetes treatment through innovative drug formulations and research initiatives.
Conclusion
Barbel Rotthauser's contributions to diabetes treatment through her patents and work at Sanofi-Aventis Deutschland GmbH highlight her dedication to improving patient care. Her innovative spirit continues to drive advancements in the pharmaceutical industry.